K. Patra

发表

Microbial transformation of tannin-rich substrate to gallic acid through co-culture method.

R. Banerjee, G. Mukherjee, K. Patra, 2005, Bioresource technology.

Role of Organizational Climate for Quality Management in Teacher Education

K. Patra, Nimai Chand Maiti, Md. Kutubuddin Halder, 2018, International Journal of Management Studies.

The pentose phosphate pathway and cancer.

N. Hay, K. Patra, 2014, Trends in biochemical sciences.

REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors

K. Ross, S. Ramaswamy, M. Mino‐Kenudson, 2020, Genes & development.

Tumor and Stem Cell Biology DDB 2 Suppresses Epithelial-to-Mesenchymal Transition in Colon Cancer

R. Benya, U. Bhat, P. Bommi, 2013 .

DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

R. Benya, U. Bhat, P. Bommi, 2013, Cancer research.

mTORC1 Hyperactivity Inhibits Serum Deprivation-Induced Apoptosis via Increased Hexokinase II and GLUT1 Expression, Sustained Mcl-1 Expression, and Glycogen Synthase Kinase 3 (cid:2) Inhibition (cid:1)

N. Hay, R. Robey, V. Nogueira, 2009 .

mTORC1 Hyperactivity Inhibits Serum Deprivation-Induced Apoptosis via Increased Hexokinase II and GLUT1 Expression, Sustained Mcl-1 Expression, and Glycogen Synthase Kinase 3β Inhibition

N. Hay, Youngkyu Park, R. Robey, 2009, Molecular and Cellular Biology.

Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration.

N. Hay, V. Nogueira, Prashanth T. Bhaskar, 2015, Cell reports.

BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis

K. Patra, Shimul A. Shah, Chrystelle L Vilfranc, 2021, World journal of hepatology.

Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma.

M. McCall, A. Hezel, N. Bardeesy, 2018, Cancer research.

A Cell Size Theory of Aging.

N. Bardeesy, K. Patra, 2018, Developmental cell.

Oncogenic PKA signaling stabilizes MYC oncoproteins via an aurora kinase A-dependent mechanism

N. Krogan, John D. Scott, N. Bardeesy, 2021, bioRxiv.

TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion-positive intrahepatic cholangiocarcinoma.

W. Hahn, G. Getz, A. Iafrate, 2019, Cancer discovery.

Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm

N. Bardeesy, K. Patra, Y. Mizukami, 2017, Clinical and translational gastroenterology.

Cytoplasmic DNA-activity during vitellogenesis in spiderAraneus nauticus koch (Aranae: Argiopidae)

K. Patra, C. Das, G. P. Verma, 1975, Experientia.

Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin

Christopher P. Long, Grace Guzman, Maciek R Antoniewicz, 2018, Nature Communications.

Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms

N. Krogan, P. Sethupathy, J. Scott, 2023, eLife.

Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.

Abhishek K. Jha, M. Laakso, W. Wheaton, 2013, Cancer cell.

A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis

N. Hay, G. Ramakrishnan, M. Frolov, 2022, Nature communications.

AMPK-Mediated Lysosome Biogenesis in Lung Cancer Growth.

N. Bardeesy, K. Patra, Vajira Kaushalya Weerasekara, 2019, Cell metabolism.

Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation

N. Hay, V. Nogueira, K. Patra, 2018, eLife.

Mutant GNAS drives pancreatic tumorigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism

M. Mino‐Kenudson, R. Sadreyev, W. Haas, 2018, Nature Cell Biology.

Hexokinase 2 as oncotarget

N. Hay, K. Patra, 2013, Oncotarget.

A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis

N. Hay, G. Ramakrishnan, M. Frolov, 2022, Nature Communications.

A novel non-catalytic scaffolding activity of Hexokinase 2 contributes to EMT and metastasis

N. Hay, G. Ramakrishnan, M. Frolov, 2021, bioRxiv.

Mutant GNAS drives pancreatic tumorigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism

M. Mino‐Kenudson, R. Sadreyev, W. Haas, 2018, Nature Cell Biology.

Ecology of planktonic copepods in the Mandarmani creek of West Bengal, India

K. Patra, R. Panigrahy, A. Mitra, 1990 .

EGFR Pathway Links Amino Acid Levels and Induction of Macropinocytosis.

N. Bardeesy, K. Patra, Vajira Kaushalya Weerasekara, 2019, Developmental cell.

Author Correction: Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin

Christopher P. Long, N. Hay, M. Antoniewicz, 2018, Nature Communications.

Integrated Programmes in Education: Development and Current Status

K. Patra, T. Basantia, 2021, Higher Education for the Future.

DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.

R. Benya, U. Bhat, P. Bommi, 2013, Cancer research.

Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma.

A. Hezel, N. Bardeesy, K. Patra, 2018, Cancer research.

Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration.

N. Hay, V. Nogueira, Prashanth T. Bhaskar, 2015, Cell Reports.